Pour les analyses bio-informatiques des programmes de recherche où nous faisons des analyses génomiques à haut débit. Cette collaboration a conduit à 10 publications communes depuis 2014.

1.   Nguyen TT, Gapihan G, Tetu P, Pamoukdjian F, El Bouchtaoui M, Leboeuf C, et al. Increased risk of brain metastases among patients with melanoma and PROM2 expression in metastatic lymph nodes. Clin Transl Med. 2020;10(8):e198.
2.   Dao T, Gapihan G, Leboeuf C, Hamdan D, Feugeas JP, Boudabous H, et al. Expression of angiopoietin-like 4 fibrinogen-like domain (cANGPTL4) increases risk of brain metastases in women with breast cancer. Oncotarget. 2020;11(18):1590-602.
3.   Bousquet G, Feugeas JP, Gu Y, Leboeuf C, Bouchtaoui ME, Lu H, et al. High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target. Oncotarget. 2019;10(61):6577-88.
4.   El Bouchtaoui M, Do Cruzeiro M, Leboeuf C, Loisel-Ferreira I, Fedronie C, Ferreira C, et al. A Constitutional Activating MET Mutation Makes the Genetic Link between Malignancies and Chronic Inflammatory Diseases. Clin Cancer Res. 2019;25(14):4504-15.
5.   Furet E, El Bouchtaoui M, Feugeas JP, Miquel C, Leboeuf C, Beytout C, et al. Increased risk of brain metastases in women with breast cancer and p16 expression in metastatic lymph-nodes. Oncotarget. 2017;8(23):37332-41.
6.   Bousquet G, El Bouchtaoui M, Sophie T, Leboeuf C, de Bazelaire C, Ratajczak P, et al. Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer. Oncotarget. 2017;8(21):35205-21.
7.   Bousquet G, El Bouchtaoui M, Leboeuf C, Battistella M, Varna M, Ferreira I, et al. Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma. Oncotarget. 2015;6(22):19279-89.
8.   Varna M, Gapihan G, Feugeas JP, Ratajczak P, Tan S, Ferreira I, et al. Stem cells increase in numbers in perinecrotic areas in human renal cancer. Clin Cancer Res. 2015;21(4):916-24.
9.   Varna M, Bousquet G, Ferreira I, Goulard M, El-Bouchtaoui M, Artus PM, et al. Stability of preclinical models of aggressive renal cell carcinomas. Int J Clin Exp Pathol. 2014;7(6):2950-62.
10. Bousquet G, Feugeas JP, Ferreira I, Vercellino L, Jourdan N, Bertheau P, et al. Individual xenograft as a personalized therapeutic resort for women with metastatic triple-negative breast carcinoma. Breast Cancer Res. 2014;16(1):401.